Top Markets
Coin of the day
Zhejiang Tianyu Pharmaceutical Co., Ltd. Zhejiang Tianyu Pharmaceutical Co., Ltd.

Zhejiang Tianyu Pharmaceutical Co., Ltd.

300702
Rank in Stocks #9157
Zhejiang Tianyu Pharmaceutical Co., Ltd. is a global enterprise specializing in... Zhejiang Tianyu Pharmaceutical Co., Ltd. is a global enterprise specializing in the entire lifecycle, from the innovation to the commercialization, of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company provides essential chemical building blocks for drugs targeting a diverse range of medical conditions, including cardiovascular disorders, diabetes, anti-atherosclerosis, blood coagulation issues, and asthma. In addition to its primary focus, the firm also delivers specialty chemicals and extends its services to include contract manufacturing (CMO) for other pharmaceutical entities. This Taizhou, China-based company was established in 1993.
Share Price
$3.10
Last synced: 2026-08-28
Market Cap
$1.08B
Change (1 day)
-1.06%
Change (1 year)
-17.63%
Country
CN
Trade Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702)

Category

P/E ratio for Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702)
P/E ratio as of 2026 TTM: 0
According to Zhejiang Tianyu Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Zhejiang Tianyu Pharmaceutical Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.